(Q45752119)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

1 reference

lymphoproliferative disorders

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

R J O'Reilly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

T N Small

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Papadopoulos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K Lucas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Koulova

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Immunopathology

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

455-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870257%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00838055

7 December 2019

exact match

0 references

cites work

The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00838055

Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00838055

Targeting frequency for deletion vectors in embryonic stem cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00838055

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

21 January 2018

1 reference

12 December 2020

Signalling downstream of activated mammalian Notch

1 reference

12 December 2020

Risk factors and pathogenesis of posttransplant lymphoproliferative disorders.

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

1 reference

12 December 2020

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

1 reference

12 December 2020

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.

1 reference

12 December 2020

Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes

1 reference

12 December 2020

A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines

1 reference

12 December 2020

Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.

1 reference

12 December 2020

Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis

1 reference

12 December 2020

Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro

1 reference

12 December 2020

Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10

1 reference

12 December 2020

Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules

1 reference

12 December 2020

Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population

1 reference

12 December 2020

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

12 December 2020

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

12 December 2020

Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.

1 reference

12 December 2020

Neoplastic consequences of transplantation and chemotherapy.

1 reference

12 December 2020

Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes

1 reference

12 December 2020

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

12 December 2020

HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1

1 reference

12 December 2020

Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

12 December 2020

The growth transformation of human B cells involves superinduction of hsp70 and hsp90.

1 reference

12 December 2020

DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1

1 reference

12 December 2020

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma

1 reference

12 December 2020

BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.

1 reference

12 December 2020

Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.

1 reference

12 December 2020

Non-Hodgkin's lymphomas and other malignancies in the acquired immune deficiency syndrome

1 reference

12 December 2020

A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level against Epstein-Barr virus-associated nuclear antigen in healthy seropositive individuals

1 reference

12 December 2020

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

1 reference

12 December 2020

Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients

1 reference

12 December 2020

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts

1 reference

12 December 2020

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

12 December 2020

Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells

1 reference

12 December 2020

Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes

1 reference

12 December 2020

Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.

1 reference

12 December 2020

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

12 December 2020

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

12 December 2020

Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen

1 reference

12 December 2020

Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.

1 reference

12 December 2020

Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer.

1 reference

12 December 2020

Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

1 reference

12 December 2020

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

1 reference

12 December 2020

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

12 December 2020

The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation

1 reference

12 December 2020

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

1 reference

12 December 2020

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

1 reference

12 December 2020

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

1 reference

12 December 2020

Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma

1 reference

12 December 2020

Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes

1 reference

12 December 2020

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

12 December 2020

Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice.

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders

1 reference

12 December 2020

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

1 reference

12 December 2020

Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease

1 reference

12 December 2020

Donor T cells to treat EBV-associated lymphoma

1 reference

12 December 2020

Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice

1 reference

12 December 2020

Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins

1 reference

12 December 2020

Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis

1 reference

12 December 2020

1 reference

12 December 2020

Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model system.

1 reference

12 December 2020

Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes

1 reference

12 December 2020

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

12 December 2020

Relationship between immunoglobulin production and immortalization by Epstein Barr virus.

1 reference

12 December 2020

The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation

1 reference

12 December 2020

Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs

1 reference

12 December 2020

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression

1 reference

12 December 2020

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

12 December 2020

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

1 reference

12 December 2020

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

12 December 2020

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

12 December 2020

The Epstein-Barr virus proteins

1 reference

12 December 2020

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

1 reference

12 December 2020

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

1 reference

12 December 2020

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

1 reference

12 December 2020

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

12 December 2020

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage

1 reference

12 December 2020

The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients

1 reference

12 December 2020

IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor

1 reference

12 December 2020

Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells

1 reference

12 December 2020

Cytotoxic T lymphocyte responses to Epstein-Barr virus

1 reference

12 December 2020

Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination

1 reference

12 December 2020

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

12 December 2020

Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus

1 reference

12 December 2020

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

1 reference

12 December 2020

Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus

1 reference

12 December 2020

Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.

1 reference

12 December 2020

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

1 reference

12 December 2020

Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis

1 reference

12 December 2020

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

12 December 2020

Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines

1 reference

12 December 2020

Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity

1 reference

12 December 2020

1 reference

12 December 2020

The tyrosine kinase lck is critically involved in the growth transformation of human B lymphocytes

1 reference

12 December 2020

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

12 December 2020

Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.

1 reference

12 December 2020

Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation

1 reference

12 December 2020

Detection and characterization of Epstein-Barr virus in clinical specimens.

1 reference

12 December 2020

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

The switch between latency and replication of Epstein-Barr virus

1 reference

12 December 2020

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

12 December 2020

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

1 reference

12 December 2020

Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma

1 reference

12 December 2020

The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)

1 reference

12 December 2020

Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders

1 reference

12 December 2020

Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice

1 reference

12 December 2020

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

12 December 2020

Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1.

1 reference

12 December 2020

Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).

1 reference

12 December 2020

Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.

1 reference

12 December 2020

Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons

1 reference

12 December 2020

Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex

1 reference

12 December 2020

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice

1 reference

12 December 2020

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

1 reference

12 December 2020

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

1 reference

12 December 2020

Long-term T-cell-mediated immunity to Epstein-Barr virus

1 reference

12 December 2020

Role of Epstein-Barr virus and interleukin 6 in the development of lymphomas of human origin in SCID mice engrafted with human tonsillar mononuclear cells

1 reference

12 December 2020

T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis

1 reference

12 December 2020

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

1 reference

12 December 2020

Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant

1 reference

12 December 2020

EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice

1 reference

12 December 2020

Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis

1 reference

12 December 2020

HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells

1 reference

12 December 2020

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

1 reference

12 December 2020

Epstein-Barr virus lymphoproliferation after bone marrow transplantation.

1 reference

12 December 2020

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

12 December 2020

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

1 reference

12 December 2020

EBV-associated lymphoproliferative syndrome with a distinct 69 base-pair deletion in the LMP-1 oncogene

1 reference

12 December 2020

Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.

1 reference

12 December 2020

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures

1 reference

12 December 2020

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

1 reference

12 December 2020

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

1 reference

12 December 2020

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis

1 reference

12 December 2020

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.

1 reference

12 December 2020

Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations

1 reference

12 December 2020

DNA of Epstein-Barr Virus. II. Comparison of the Molecular Weights of Restriction Endonuclease Fragments of the DNA of Epstein-Barr Virus Strains and Identification of End Fragments of the B95-8 Strain

1 reference

12 December 2020

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

12 December 2020

Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes

1 reference

12 December 2020

Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS

1 reference

12 December 2020

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

12 December 2020

Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma

1 reference

12 December 2020

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

1 reference

12 December 2020

Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice

1 reference

12 December 2020

AIDS-associated non-Hodgkin's lymphoma in San Francisco

1 reference

12 December 2020

Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals.

1 reference

12 December 2020

Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation

1 reference

12 December 2020

Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients

1 reference

12 December 2020

Epstein-Barr virus infection and immunoregulation in man.

1 reference

12 December 2020

Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals

1 reference

12 December 2020

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

12 December 2020

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

1 reference

12 December 2020

Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation

1 reference

12 December 2020

A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.

1 reference

12 December 2020

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

1 reference

12 December 2020

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

12 December 2020

Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma

1 reference

12 December 2020

Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population

1 reference

12 December 2020

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

12 December 2020

Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients

1 reference

12 December 2020

Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens

1 reference

12 December 2020

Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4

1 reference

12 December 2020

Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory

1 reference

12 December 2020

Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcr

1 reference

12 December 2020

Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines

1 reference

12 December 2020

Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.

1 reference

12 December 2020

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity

1 reference

12 December 2020

Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.

1 reference

12 December 2020

Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene.

1 reference

12 December 2020

Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow ino

1 reference

12 December 2020

Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype.

1 reference

12 December 2020

Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

1 reference

12 December 2020

IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function

1 reference

12 December 2020

Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus

1 reference

12 December 2020

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

1 reference

12 December 2020

The Epstein-Barr virus and the immune system

1 reference

12 December 2020

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

1 reference

12 December 2020

Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice.

1 reference

12 December 2020

Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies

1 reference

12 December 2020

Generation of tumor-specific T lymphocytes for the treatment of posttransplant lymphoma.

1 reference

12 December 2020

Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.

1 reference

12 December 2020

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

12 December 2020

Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.

1 reference

12 December 2020

Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis

1 reference

12 December 2020

Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants

1 reference

12 December 2020

Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity

1 reference

12 December 2020

Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease

1 reference

12 December 2020

Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.

1 reference

12 December 2020

Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders

1 reference

12 December 2020

Pretransplantation assessment of the risk of lymphoproliferative disorder

1 reference

12 December 2020

Epstein-Barr Virus In B Lymphocytes: Viral Gene Expression and Function in Latency

1 reference

12 December 2020

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

1 reference

12 December 2020

Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells

1 reference

12 December 2020

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

1 reference

12 December 2020

Antiproliferative effect of antilymphocyte globulins on B cells and B-cell lines

1 reference

12 December 2020

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

12 December 2020

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

1 reference

12 December 2020

Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment

1 reference

12 December 2020

Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group

1 reference

12 December 2020

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

12 December 2020

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

12 December 2020

The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases

1 reference

12 December 2020

HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies

1 reference

12 December 2020